Home    Our Technology    Development Pipeline    Press    News & Articles    About Us    Contact Us     Dengue Fever
DENGUE FEVER SPOTLIGHT & FACTS

- Dengue haemorrhagic fever (DHF), a potentially lethal complication, was first recognized in the 1950s..

- 2.5 billion people – two fifths of the world's population – are now at risk

- In 2007 alone, there were more than 890 000 reported cases of dengue in the Americas.

- The disease is now endemic in more than 100 countries in Africa, the Americas, the Eastern Mediterranean, South-east Asia and the Western Pacific

- An estimated 500 000 people with DHF require hospitalization each year...

- About 2.5% of those affected die,a very large proportion being children.

- Without proper treatment, DHF fatality rates can exceed 20%..
NEWS & ARTICLES
Arbovax Aims to Remove the Sting from Mosquito-Borne Diseases
 You can't take the bite out of the mosquito, but a small Raleigh biotechnology company could become very big by taking the might out of that sometimes dead..

Arbovax, Inc. and Immunobiosciences, Inc announce a Collaborative Agreement on Dengue Vaccine Research
Arbovax, Inc (Arbovax) and Immunobiosciences, Inc (IBI) today announced that they will initiate research collaboration on the development of safe and effective ..
CONTACT US

Malcolm Thomas
President and Chief Executive Officer

617 Hutton Street
Suite 101
Raleigh NC 27606-6301

Phone 919.655.0412
Fax 919.655.0413

 

CONTACT FORM
First Name:
Last Name:
Your Email:
Your Telephone #:
Country:
Request:

 

    Home    Our Technology    Development Pipeline    News & Articles    About Us    Contact Us     Dengue Fever

Arbovax.com © 2008. All rights reserved | Web Site developed by eCaribbean Ltd